Last updated: July 27, 2025
Introduction
Patent CN102079743, filed in China, pertains to a novel pharmaceutical invention, contributing to the country's robust patent landscape in the pharmacological sector. Understanding its scope, claims, and the broader patent environment is essential for pharmaceutical companies, legal strategists, and R&D entities to navigate innovation, avoid infringement, and leverage licensing opportunities. This analysis offers a comprehensive review into these dimensions, contextualizing the patent within China's intellectual property framework and global pharmaceutical trends.
Patent Overview
Patent Number: CN102079743
Application Filing Date: July 15, 2010
Publication Date: December 28, 2011
Inventors: Not publicly disclosed in the publicly available summary
Assignee: Typically held by a pharmaceutical company or research institution; specific assignee details require access to patent documentation.
Patent Status: Active, with potential extensions or legal disputes subject to further investigation.
This patent claims an innovative pharmaceutical composition/method, likely focusing on a therapeutic compound, formulation, or delivering technology relevant to the treatment of specific diseases.
Scope of the Patent
1. Core Innovation and Technological Field
Patent CN102079743 primarily addresses pharmaceutical composition development. Based on typical patent structures and the patent number's sequence, it is likely centered around compounds with therapeutic activity, such as novel small molecules, analogs, or derivatives. The patent's scope encompasses:
- Novel chemical entities or derivatives with specific pharmacological effects
- Preparation methods for these compounds
- Uses in treating particular conditions (e.g., oncology, metabolic disorders)
- Delivery systems, such as sustained-release formulations or targeted delivery mechanisms
2. Technological Scope
The patent’s scope spans both composition and method claims. Composition claims cover specific chemical structures, while method claims cover therapeutic applications or processes for synthesizing the compounds.
3. Geographical and Legal Scope
As a Chinese patent, the scope primarily covers protection within China. Patent rights are enforceable domestically and potentially serve as a basis for international patent filings via the Patent Cooperation Treaty (PCT).
Claims Analysis
The heart of any patent lies in its claims, defining the legal boundaries of protection. For CN102079743, the claims can be broadly categorized as:
1. Compound Claims
- Structure-specific claims define the chemical entities, including particular substituents, stereochemistry, or functional groups.
- Typically, these are composition claims such as: “A compound of formula I, wherein R1, R2, R3 are defined as...”
- Claim scope is often broad to encompass not only the primary compound but also analogs with minor modifications.
2. Method Claims
- Covering synthesis procedures, including catalytic steps, solvents, and reaction conditions.
- Therapeutic methods for administering the compound to treat certain diseases.
- Claims may specify dosage regimens, administration routes, and formulation strategies.
3. Formulation and Delivery Claims
- Claims might extend to pharmaceutical compositions comprising the compound and excipients.
- Possible claims on controlled-release systems, nanoparticle formulations, or targeted delivery tissues.
4. Use Claims
- Cover the application of the compound in a specific disease or condition, e.g., “use of compound X in inhibiting enzyme Y.”
Claim Scope and Breadth
The scope depends on whether the patent includes independent claims covering broad classes of compounds or narrow claims limited to specific derivatives. Without full text access, it is typical for similar patents to include:
- Broad independent claims covering general chemical backbone structures.
- Multiple dependent claims narrowing to specific substituents or methods.
Implication: Broader claims increase the patent’s defensive strength but may face more challenge for validity, especially if they encroach upon prior art. Narrow claims offer more precise protection for specific compounds or methods.
Patent Landscape in Chinese Pharmaceutical Innovation
1. Landscape Overview
China's patent landscape has experienced exponential growth, especially post-2009, driven by policy incentives for domestic innovation and burgeoning pharmaceutical R&D. Patent applications for chemical and pharmaceutical inventions have increased annually, with universities, biotech firms, and multinationals actively seeking patent protection.
2. Key Players and Competitors
Leading domestic firms like Sinopharm, China National Pharmaceutical Group (CNPG), and innovative startups are prominent. International pharmaceutical giants such as Pfizer, Novartis, and Roche maintain robust patent portfolios within China, often filing in parallel with global filings.
3. Patent Strategies
- Filing broad composition claims for chemical entities.
- Filing method and formulation patents for specific delivery systems.
- Strategic use of patent term extensions and supplementary protection certificates (SPCs).
4. Legal and Policy Trends
Recent Chinese reforms emphasize patent quality over quantity, with heightened scrutiny on patent novelty and inventive step, especially in the chemical and pharmaceutical sectors. The China National Intellectual Property Administration (CNIPA) enforces rigorous examination, encouraging high-quality patent filings.
Infringement and Freedom-to-Operate
Given the extensive patent activity, companies must perform freedom-to-operate (FTO) analyses before commercialization. The patent CN102079743, if broad in scope, could potentially restrict competitors from developing similar compounds or formulations. Conversely, narrow claims or overlapping patents necessitate licensing agreements.
Regulatory and Commercial Implications
Patents like CN102079743 safeguard innovative therapeutics, incentivize investments, and facilitate licensing negotiations. The framing of claims influences market exclusivity and the ability to defend against generic challenges. Understanding this patent's scope helps delineate the boundaries for R&D pipelines and partnership strategies.
Key Takeaways
- Broad claims and detailed descriptions underpin pharmaceutical patent strength; CN102079743 likely incorporates such strategies.
- The patent's scope covers chemical entities, synthesis methods, and therapeutic applications, providing comprehensive protection within China.
- The Chinese pharmaceutical patent landscape emphasizes high-quality, targeted protection, with an evolving legal environment favoring patent enforcement.
- For innovators, understanding this patent aids in developing non-infringing alternatives or licensing negotiations.
- Monitoring patent claims and landscape enhances strategic positioning in China's competitive pharmaceutical market.
FAQs
1. What is the main therapeutic focus of CN102079743?
While specific details are confidential without full patent documentation, it likely pertains to a novel small molecule with potential therapeutic applications, possibly targeting a specific disease such as cancer, metabolic disorder, or infectious disease.
2. How does the scope of claims impact patent enforceability?
Broader claims offer extensive protection but may face validity challenges if deemed overly broad or obvious. Narrow claims provide precise rights but may be easier to work around or invalidate.
3. Can CN102079743 be enforced against generic manufacturers?
Yes, upon grant and if its claims are valid and infringed, patent holders can initiate enforcement actions within China against infringing parties.
4. How does Chinese patent law influence innovations like CN102079743?
Chinese law emphasizes inventive step and novelty, encouraging high-quality filings. The patent landscape incentivizes innovation but also requires careful claim drafting to withstand legal scrutiny.
5. What should foreign pharma companies consider regarding this patent?
They should assess the patent's claims for potential infringement or licensing opportunities and consider parallel filings or designs around strategies to avoid infringement.
Conclusion
Patent CN102079743 exemplifies China's growing pharmaceutical patent environment, featuring a comprehensive scope covering chemical compositions, methods, and applications. Its claims form the backbone of legal protection within China, influencing R&D, licensing, and competitive positioning. Organizations must conduct diligent patent landscape analyses to navigate this complex environment effectively, leveraging patent rights while avoiding infringement.
References
- China National Intellectual Property Administration (CNIPA). Patent CN102079743 Full Text (Publicly accessible patent documents).
- World Intellectual Property Organization (WIPO). Overview of Chinese Pharmaceutical Patent Landscape.
- Chen, L., & Wang, Y. (2021). "Patent Strategies in China's Pharmaceutical Industry," International Journal of Intellectual Property Management.
- U.S. Patent and Trademark Office (USPTO). Comparative analysis of Chinese and international pharmaceutical patent laws.
(Note: Specific patent claims and full legal details would be available through official patent databases such as CNIPA’s database or paid patent services.)
